
Steve Yang, Ph.D.
Co-CEO
A pharmaceutical industry leader recognized for building R&D and service capabilities, delivering research and early development portfolios of drug candidates, and establishing R&D partnerships in US, Europe, China and other Asian and emerging markets. Before joining WuXi AppTec, Dr. Yang was Vice President and Head of Asia and Emerging Markets IMED at AstraZeneca, and served as Vice President and Head of Asia R&D at Pfizer and as Executive Director and head of Pfizer's global R&D strategic management group. Dr. Yang received his Ph.D. in pharmaceutical chemistry from the University of California, San Francisco.

Xuanjia Peng, Ph.D.
Vice President, Head of WuXi Biology
Xuanjia Peng received his Ph.D. in organic chemistry from Lanzhou University and then joined in WuXi AppTec. During his years at WuXi AppTec, he has achieved breakthroughs in numerous medicinal projects and owns more than 100 academic patents. Dr. Peng has remarkable leadership in various areas exerting significant influence in the industry and within the company.